Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression
Obesity Reviews · 2024-07 · 25 (7)
DOI: 10.1111/obr.13744 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Obesity Reviews, online erschienen am 04.04.2024. Verfasst von Suhaniya N S Samarasinghe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Obesity, Overweight, Insulin Resistance. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive‐age women. This systematic review, meta‐analysis, and meta‐regression aims to compare the effect of insulin sensitizer pharmacotherapy on metabolic and reproductive outcomes in women with PCOS and overweight or obesity. We searched online databases MEDLINE via OVID, EMBASE, Clinicaltrials.gov , and EudraCT for trials published from inception to November 13, 2023. Inclusion criteria were double‐blind, randomized controlled trials in women diagnosed with PCOS, body mass index (BMI) ≥ 25 kg/m 2 , which reported metabolic or reproductive outcomes. The intervention was insulin sensitization pharmacotherapy versus placebo or other agents. The primary outcomes were changes from baseline BMI, fasting blood glucose, and menstrual frequency. Nineteen studies were included in this review. Metformin had the most significant effect on the fasting plasma glucose and body mass index. Insulin sensitizer pharmacotherapy significantly reduced fasting plasma glucose, body mass index, fasting serum insulin, HOMA‐IR, sex hormone binding globulin, and total testosterone, but the effect size was small. There was a lack of menstrual frequency and live birth data. The results indicate a role for insulin sensitizers in improving the metabolic and, to a lesser degree, reproductive profile in these women. Further research should examine insulin sensitizers' effects on objective measures of fecundity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
- Institute for Translational Medicine, University of Pecs Medical School, Pécs, Hungary.
- Faculty of Medicine, J. J. Strossmayer University of Osijek, Osijek, Croatia.
- Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Department of Surgery and Cancer, Imperial College London, London, UK.
- Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, London, UK.
ORCID-Profile: Suhaniya N S Samarasinghe
Zitieren
APA
Samarasinghe, S. N. S., Ostarijas, E., Long, M. J., Erridge, S., Purkayastha, S., Dimitriadis, G. K., & Miras, A. D. (2024). Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression. Obesity Reviews, 25(7). https://doi.org/10.1111/obr.13744
Vancouver
Samarasinghe SNS, Ostarijas E, Long MJ, Erridge S, Purkayastha S, Dimitriadis GK, et al. Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression. Obesity Reviews. 2024;25(7). doi:10.1111/obr.13744
BibTeX
@article{Samarasinghe2024,
author = {Samarasinghe, Suhaniya N S and Ostarijas, Eduard and Long, Matthew J and Erridge, Simon and Purkayastha, Sanjay and Dimitriadis, Georgios K and Miras, Alexander D},
title = {Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression},
journal = {Obesity Reviews},
year = {2024},
volume = {25},
number = {7},
doi = {10.1111/obr.13744}
}
EUVIMED